Ajanta Pharma Limited (NSE:AJANTPHARM)
India flag India · Delayed Price · Currency is INR
2,695.20
-56.20 (-2.04%)
Aug 1, 2025, 3:29 PM IST

Ajanta Pharma Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
48,05846,48142,08737,42633,41028,897
Upgrade
Revenue Growth (YoY)
10.92%10.44%12.45%12.02%15.62%11.66%
Upgrade
Cost of Revenue
11,50911,42911,21011,1028,8406,832
Upgrade
Gross Profit
36,54935,05230,87726,32424,57022,065
Upgrade
Selling, General & Admin
11,23911,0489,1227,9786,5715,523
Upgrade
Other Operating Expenses
12,12311,2799,94410,2418,6676,478
Upgrade
Operating Expenses
24,87623,76820,42019,52716,49113,162
Upgrade
Operating Income
11,67311,28510,4576,7988,0798,903
Upgrade
Interest Expense
-252.6-207.3-72.1-58.4-102-82.7
Upgrade
Interest & Investment Income
471.6471.6277.184.6146.535.1
Upgrade
Currency Exchange Gain (Loss)
41.8282.1158.7660.7563.745.1
Upgrade
Other Non Operating Income (Expenses)
28.841.4264.161.5323.840.9
Upgrade
EBT Excluding Unusual Items
11,96311,87211,0847,5469,0118,941
Upgrade
Gain (Loss) on Sale of Investments
25.225.220.1-40122.882.7
Upgrade
Gain (Loss) on Sale of Assets
-6-634.9-53.5-38.7-22.1
Upgrade
Pretax Income
11,98211,89211,1397,4539,0959,002
Upgrade
Income Tax Expense
2,6822,6882,9781,5731,9682,463
Upgrade
Net Income
9,3009,2048,1625,8807,1276,539
Upgrade
Net Income to Common
9,3009,2048,1625,8807,1276,539
Upgrade
Net Income Growth
8.92%12.77%38.81%-17.50%8.99%39.80%
Upgrade
Shares Outstanding (Basic)
125125126128130131
Upgrade
Shares Outstanding (Diluted)
125125126128130131
Upgrade
Shares Change (YoY)
-0.82%-0.66%-1.65%-1.19%-0.74%-0.21%
Upgrade
EPS (Basic)
74.4573.5664.8245.8954.9750.06
Upgrade
EPS (Diluted)
74.4273.5364.7745.8954.9650.06
Upgrade
EPS Growth
9.82%13.53%41.14%-16.50%9.79%40.09%
Upgrade
Free Cash Flow
-8,3936,3276,1764,1294,047
Upgrade
Free Cash Flow Per Share
-67.0550.2148.2031.8430.98
Upgrade
Dividend Per Share
28.00028.00036.0007.0006.3336.333
Upgrade
Dividend Growth
7.69%-22.22%414.29%10.53%--26.92%
Upgrade
Gross Margin
76.05%75.41%73.36%70.34%73.54%76.36%
Upgrade
Operating Margin
24.29%24.28%24.84%18.16%24.18%30.81%
Upgrade
Profit Margin
19.35%19.80%19.39%15.71%21.33%22.63%
Upgrade
Free Cash Flow Margin
-18.06%15.03%16.50%12.36%14.01%
Upgrade
EBITDA
12,92512,52211,6387,9529,1739,889
Upgrade
EBITDA Margin
26.89%26.94%27.65%21.25%27.46%34.22%
Upgrade
D&A For EBITDA
1,2521,2381,1811,1541,094985.9
Upgrade
EBIT
11,67311,28510,4576,7988,0798,903
Upgrade
EBIT Margin
24.29%24.28%24.84%18.16%24.18%30.81%
Upgrade
Effective Tax Rate
22.38%22.60%26.73%21.10%21.64%27.36%
Upgrade
Revenue as Reported
49,00247,42642,93338,41334,56729,157
Upgrade
Advertising Expenses
-57.644.950.247.816.2
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.